-
1دورية أكاديمية
المؤلفون: Bianca J. Lee, Sharmila Mallya, Nuntana Dinglasan, Amos Fung, Tram Nguyen, Lee-or Herzog, Joshua Thao, Edward G. Lorenzana, David Wildes, Mallika Singh, Jacqueline A. M. Smith, David A. Fruman
المصدر: Frontiers in Oncology, Vol 11 (2021)
مصطلحات موضوعية: mTORC1, targeted (selective) treatment, 4EBP1, combination therapy, Ph+ B-ALL, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2
المؤلفون: Nancy Nguyen, Ze'ev Ronai, Sharmila Mallya, Roberta Buono, J. Scott Lee, Anthony B. Pinkerton, Boyang Li, Amos Fung, David A. Fruman, Michael R. Jackson, Beth Walters, Lee-or Herzog, Robert J. Schneider, Honyin Chiu
المصدر: British Journal of Cancer
British journal of cancer, vol 124, iss 6مصطلحات موضوعية: Cancer Research, Lymphoma, Drug Resistance, Apoptosis, Mice, SCID, Quinolones, chemistry.chemical_compound, Eukaryotic initiation factor 4F, Mice, 0302 clinical medicine, Mice, Inbred NOD, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Tumor Cells, Cultured, Molecular Targeted Therapy, Cancer, Sulfonamides, Cultured, Molecular medicine, Kinase, B-cell lymphoma, Heterocyclic, Hematology, Tumor Cells, Oncology, 030220 oncology & carcinogenesis, Public Health and Health Services, Female, Lymphoma, B-Cell, Lactams, Oncology and Carcinogenesis, SCID, Article, 03 medical and health sciences, Bridged Bicyclo Compounds, Eukaryotic translation, Rare Diseases, medicine, Initiation factor, Animals, Humans, Oncology & Carcinogenesis, PI3K/AKT/mTOR pathway, Cell Proliferation, Venetoclax, B-Cell, medicine.disease, Bridged Bicyclo Compounds, Heterocyclic, Xenograft Model Antitumor Assays, Eukaryotic Initiation Factor-4E, chemistry, Drug Resistance, Neoplasm, Cancer research, Inbred NOD, Neoplasm, Mantle cell lymphoma
وصف الملف: application/pdf
-
3
المؤلفون: Mallika Singh, Bianca J. Lee, Joshua Thao, Edward G. Lorenzana, David Wildes, Tram Nguyen, Jacqueline Smith, Amos Fung, Lee-or Herzog, David A. Fruman, Sharmila Mallya, Nuntana Dinglasan
المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Pediatric Cancer, Childhood Leukemia, targeted (selective) treatment, Oncology and Carcinogenesis, mTORC1, mTORC2, Ph+ B-ALL, combination therapy, 03 medical and health sciences, Rare Diseases, 0302 clinical medicine, Ph plus B-ALL, medicine, Mechanistic target of rapamycin, RC254-282, PI3K/AKT/mTOR pathway, Original Research, Cancer, Pediatric, 4EBP1, biology, Chemistry, Kinase, Cell growth, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Hematology, medicine.disease, Dasatinib, Leukemia, Orphan Drug, 030104 developmental biology, Oncology, 5.1 Pharmaceuticals, 030220 oncology & carcinogenesis, biology.protein, Cancer research, biological phenomena, cell phenomena, and immunity, Development of treatments and therapeutic interventions, medicine.drug
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77ef2bee04da5088b82a5545dba23075
https://doi.org/10.3389/fonc.2021.673213 -
4
المؤلفون: Jacqueline Smith, Amos Fung, Bianca J. Lee, Ze'ev Ronai, Honyin Chiu, Thanh-Trang Vo, Lee-or Herzog, David A. Fruman, James B. Aggen, Nidhi Tibrewal, David Wildes, Davide Ruggero, Mallika Singh, Sharmila Mallya
المصدر: Molecular Cancer Research. 18:IA17-IA17
مصطلحات موضوعية: Cancer Research, Venetoclax, P70-S6 Kinase 1, mTORC1, medicine.disease, mTORC2, Dasatinib, chemistry.chemical_compound, Leukemia, Oncology, chemistry, B-cell leukemia, medicine, Cancer research, Molecular Biology, PI3K/AKT/mTOR pathway, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1e13b2572f81419efb863417a60e5ba8
https://doi.org/10.1158/1557-3125.pi3k-mtor18-ia17
Full Text Finder 
Find this article in full text from Springer Verlag.